Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

0
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Category

Show more Refine

For: Ward JE, Karrison T, Chatta G, Hussain M, Shevrin D, Szmulewitz RZ, O’Donnell PH, Stadler WM, Posadas EM. A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study. Prostate Cancer Prostatic Dis 2012;15:87-92. [PMID: 22006050 PMCID: PMC4312616 DOI: 10.1038/pcan.2011.49] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2011] [Revised: 08/29/2011] [Accepted: 09/01/2011] [Indexed: 11/09/2022]

For:	Ward JE, Karrison T, Chatta G, Hussain M, Shevrin D, Szmulewitz RZ, O’Donnell PH, Stadler WM, Posadas EM. A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study. Prostate Cancer Prostatic Dis 2012;15:87-92. [PMID: 22006050 PMCID: PMC4312616 DOI: 10.1038/pcan.2011.49] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2011] [Revised: 08/29/2011] [Accepted: 09/01/2011] [Indexed: 11/09/2022]

No articles found.

(The first 100,000 artilces are displayed in RCA.)